Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii

Research output: Contribution to journalArticle

Abstract

The exact mechanisms of action of some antipsychotics and mood stabilizers have not been elucidated. Response to these medications can vary among individuals. Recent studies indicate that infection with the parasite Toxoplasma gondii may contribute to the symptoms of schizophrenia in some individuals. We investigated commonly used antipsychotic and mood stabilizing medications for their ability to inhibit the replication of this organism. We employed a system for testing compounds for in vitro activity against T. gondii. Human fibroblasts (HFF) were treated with test compounds and then exposed to Toxoplasma that has been genetically modified to express cytoplasmic β-galactosidase. Inhibition by the drugs was determined by spectrophotometric analysis of colorimetric reactions. We tested 12 neuroleptic compounds and found that of these, the antipsychotic haloperidol and the mood stabilizer valproic acid most effectively inhibit Toxoplasma growth in vitro. Valproic acid inhibited the parasite at a concentration below that found in the cerebrospinal fluid and blood of individuals being treated with this medication and displayed synergistic activity with haloperidol and with trimethoprim, an antibiotic commonly used to treat Toxoplasma infections. Several medications used to treat schizophrenia and bipolar disorder have the ability to inhibit the in vitro replication of T. gondii.

Original languageEnglish (US)
Pages (from-to)237-244
Number of pages8
JournalSchizophrenia Research
Volume62
Issue number3
DOIs
StatePublished - Aug 1 2003

Fingerprint

Toxoplasma
Bipolar Disorder
Schizophrenia
Antipsychotic Agents
Pharmaceutical Preparations
Aptitude
Valproic Acid
Haloperidol
Therapeutics
Galactosidases
Parasitic Diseases
Trimethoprim
Cerebrospinal Fluid
Parasites
Fibroblasts
Anti-Bacterial Agents
Growth
Infection
In Vitro Techniques

Keywords

  • Antiparasitic
  • Antipsychotics
  • Bipolar disorder
  • Mood stabilizers
  • Parasite
  • Schizophrenia

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Behavioral Neuroscience
  • Biological Psychiatry
  • Neurology
  • Psychology(all)

Cite this

Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii. / Brando, Lorraine V; Torrey, E. Fuller; Yolken, Robert H.

In: Schizophrenia Research, Vol. 62, No. 3, 01.08.2003, p. 237-244.

Research output: Contribution to journalArticle

@article{fca88ef7eb6145c9ab4ff211ba51ff11,
title = "Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii",
abstract = "The exact mechanisms of action of some antipsychotics and mood stabilizers have not been elucidated. Response to these medications can vary among individuals. Recent studies indicate that infection with the parasite Toxoplasma gondii may contribute to the symptoms of schizophrenia in some individuals. We investigated commonly used antipsychotic and mood stabilizing medications for their ability to inhibit the replication of this organism. We employed a system for testing compounds for in vitro activity against T. gondii. Human fibroblasts (HFF) were treated with test compounds and then exposed to Toxoplasma that has been genetically modified to express cytoplasmic β-galactosidase. Inhibition by the drugs was determined by spectrophotometric analysis of colorimetric reactions. We tested 12 neuroleptic compounds and found that of these, the antipsychotic haloperidol and the mood stabilizer valproic acid most effectively inhibit Toxoplasma growth in vitro. Valproic acid inhibited the parasite at a concentration below that found in the cerebrospinal fluid and blood of individuals being treated with this medication and displayed synergistic activity with haloperidol and with trimethoprim, an antibiotic commonly used to treat Toxoplasma infections. Several medications used to treat schizophrenia and bipolar disorder have the ability to inhibit the in vitro replication of T. gondii.",
keywords = "Antiparasitic, Antipsychotics, Bipolar disorder, Mood stabilizers, Parasite, Schizophrenia",
author = "Brando, {Lorraine V} and Torrey, {E. Fuller} and Yolken, {Robert H}",
year = "2003",
month = "8",
day = "1",
doi = "10.1016/S0920-9964(02)00357-2",
language = "English (US)",
volume = "62",
pages = "237--244",
journal = "Schizophrenia Research",
issn = "0920-9964",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii

AU - Brando, Lorraine V

AU - Torrey, E. Fuller

AU - Yolken, Robert H

PY - 2003/8/1

Y1 - 2003/8/1

N2 - The exact mechanisms of action of some antipsychotics and mood stabilizers have not been elucidated. Response to these medications can vary among individuals. Recent studies indicate that infection with the parasite Toxoplasma gondii may contribute to the symptoms of schizophrenia in some individuals. We investigated commonly used antipsychotic and mood stabilizing medications for their ability to inhibit the replication of this organism. We employed a system for testing compounds for in vitro activity against T. gondii. Human fibroblasts (HFF) were treated with test compounds and then exposed to Toxoplasma that has been genetically modified to express cytoplasmic β-galactosidase. Inhibition by the drugs was determined by spectrophotometric analysis of colorimetric reactions. We tested 12 neuroleptic compounds and found that of these, the antipsychotic haloperidol and the mood stabilizer valproic acid most effectively inhibit Toxoplasma growth in vitro. Valproic acid inhibited the parasite at a concentration below that found in the cerebrospinal fluid and blood of individuals being treated with this medication and displayed synergistic activity with haloperidol and with trimethoprim, an antibiotic commonly used to treat Toxoplasma infections. Several medications used to treat schizophrenia and bipolar disorder have the ability to inhibit the in vitro replication of T. gondii.

AB - The exact mechanisms of action of some antipsychotics and mood stabilizers have not been elucidated. Response to these medications can vary among individuals. Recent studies indicate that infection with the parasite Toxoplasma gondii may contribute to the symptoms of schizophrenia in some individuals. We investigated commonly used antipsychotic and mood stabilizing medications for their ability to inhibit the replication of this organism. We employed a system for testing compounds for in vitro activity against T. gondii. Human fibroblasts (HFF) were treated with test compounds and then exposed to Toxoplasma that has been genetically modified to express cytoplasmic β-galactosidase. Inhibition by the drugs was determined by spectrophotometric analysis of colorimetric reactions. We tested 12 neuroleptic compounds and found that of these, the antipsychotic haloperidol and the mood stabilizer valproic acid most effectively inhibit Toxoplasma growth in vitro. Valproic acid inhibited the parasite at a concentration below that found in the cerebrospinal fluid and blood of individuals being treated with this medication and displayed synergistic activity with haloperidol and with trimethoprim, an antibiotic commonly used to treat Toxoplasma infections. Several medications used to treat schizophrenia and bipolar disorder have the ability to inhibit the in vitro replication of T. gondii.

KW - Antiparasitic

KW - Antipsychotics

KW - Bipolar disorder

KW - Mood stabilizers

KW - Parasite

KW - Schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=0037787955&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037787955&partnerID=8YFLogxK

U2 - 10.1016/S0920-9964(02)00357-2

DO - 10.1016/S0920-9964(02)00357-2

M3 - Article

C2 - 12837520

AN - SCOPUS:0037787955

VL - 62

SP - 237

EP - 244

JO - Schizophrenia Research

JF - Schizophrenia Research

SN - 0920-9964

IS - 3

ER -